Literature DB >> 7651428

RAS signalling is abnormal in a c-raf1 MEK1 double mutant.

D Bottorff1, S Stang, S Agellon, J C Stone.   

Abstract

A mutant rat cell clone that suppresses the transformation defects of RAS effector loop substitutions is heterozygous for mutations in c-raf1 and MEK1. The mutant cells can be transformed by many otherwise defective RAS effector mutants, including RAS genes with the effector regions of distantly related GTPases, even though the encoded RAS proteins do not interact with either the mutant or wild-type RAF in Saccharomyces cerevisiae. While the significance of the c-raf1 mutation is unclear, the MEK1 mutation increases MEK1 activity and leads to activation of mitogen-activated protein kinase. The mutant MEK1 is coupled to the epidermal growth factor pathway but exhibits decreased physical interaction with RAF. When overexpressed, the MEK1 mutation is transforming and causes hyperphosphorylation of RAF. Signalling from RAS to MEK1 may be mediated by something other than RAF alone, but signalling through MEK1 is probably sufficient for RAS transformation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651428      PMCID: PMC230758          DOI: 10.1128/MCB.15.9.5113

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Activation of the MAP kinase pathway by the protein kinase raf.

Authors:  L R Howe; S J Leevers; N Gómez; S Nakielny; P Cohen; C J Marshall
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

2.  The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product.

Authors:  C M Crews; A Alessandrini; R L Erikson
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

3.  Raf-1 and p21v-ras cooperate in the activation of mitogen-activated protein kinase.

Authors:  N G Williams; H Paradis; S Agarwal; D L Charest; S L Pelech; T M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

4.  Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.

Authors:  X F Zhang; J Settleman; J M Kyriakis; E Takeuchi-Suzuki; S J Elledge; M S Marshall; J T Bruder; U R Rapp; J Avruch
Journal:  Nature       Date:  1993-07-22       Impact factor: 49.962

Review 5.  The mitogen-activated protein kinase signal transduction pathway.

Authors:  R J Davis
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

6.  Complex formation between RAS and RAF and other protein kinases.

Authors:  L Van Aelst; M Barr; S Marcus; A Polverino; M Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Protein kinase C alpha activates RAF-1 by direct phosphorylation.

Authors:  W Kolch; G Heidecker; G Kochs; R Hummel; H Vahidi; H Mischak; G Finkenzeller; D Marmé; U R Rapp
Journal:  Nature       Date:  1993-07-15       Impact factor: 49.962

8.  Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.

Authors:  P H Warne; P R Viciana; J Downward
Journal:  Nature       Date:  1993-07-22       Impact factor: 49.962

9.  Functional analysis of a growth factor-responsive transcription factor complex.

Authors:  C S Hill; R Marais; S John; J Wynne; S Dalton; R Treisman
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

10.  Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase.

Authors:  S A Moodie; B M Willumsen; M J Weber; A Wolfman
Journal:  Science       Date:  1993-06-11       Impact factor: 47.728

View more
  13 in total

1.  Hypothermic stress leads to activation of Ras-Erk signaling.

Authors:  E Y Chan; S L Stang; D A Bottorff; J C Stone
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Neural cell adhesion molecule-stimulated neurite outgrowth depends on activation of protein kinase C and the Ras-mitogen-activated protein kinase pathway.

Authors:  K Kolkova; V Novitskaya; N Pedersen; V Berezin; E Bock
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

3.  Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.

Authors:  R Khosravi-Far; M A White; J K Westwick; P A Solski; M Chrzanowska-Wodnicka; L Van Aelst; M H Wigler; C J Der
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

4.  Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo.

Authors:  Joon-Ho Sheen; Roberto Zoncu; Dohoon Kim; David M Sabatini
Journal:  Cancer Cell       Date:  2011-05-17       Impact factor: 31.743

5.  Interaction of activated Ras with Raf-1 alone may be sufficient for transformation of rat2 cells.

Authors:  S Stang; D Bottorff; J C Stone
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

6.  Activation of the p42 mitogen-activated protein kinase pathway inhibits Cdc2 activation and entry into M-phase in cycling Xenopus egg extracts.

Authors:  J C Bitangcol; A S Chau; E Stadnick; M J Lohka; B Dicken; E K Shibuya
Journal:  Mol Biol Cell       Date:  1998-02       Impact factor: 4.138

7.  Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival.

Authors:  Matthias Drosten; Alma Dhawahir; Eleanor Y M Sum; Jelena Urosevic; Carmen G Lechuga; Luis M Esteban; Esther Castellano; Carmen Guerra; Eugenio Santos; Mariano Barbacid
Journal:  EMBO J       Date:  2010-02-11       Impact factor: 11.598

8.  MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival.

Authors:  Chih-Shia Lee; Liam C Lee; Tina L Yuan; Sirisha Chakka; Christof Fellmann; Scott W Lowe; Natasha J Caplen; Frank McCormick; Ji Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-01       Impact factor: 11.205

9.  Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma.

Authors:  Jenifer L Marks; Yixuan Gong; Dhananjay Chitale; Ben Golas; Michael D McLellan; Yumi Kasai; Li Ding; Elaine R Mardis; Richard K Wilson; David Solit; Ross Levine; Kathrin Michel; Roman K Thomas; Valerie W Rusch; Marc Ladanyi; William Pao
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

10.  Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling.

Authors:  A W Lin; M Barradas; J C Stone; L van Aelst; M Serrano; S W Lowe
Journal:  Genes Dev       Date:  1998-10-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.